Cyanobacterial pigment protein allophycocyanin exhibits longevity and reduces Aβ-mediated paralysis in : complicity of FOXO and NRF2 ortholog DAF-16 and SKN-1.

The allophycocyanin (APC) protein purified from sp. A09DM was investigated for its in vivo antioxidant and anti-aging potential in . An increased mean lifespan of APC-treated (100 μg/ml) worms (wild type) were observed from 16 ± 0.2 days (control) to 20 ± 0.1 days (treated). APC-treated worms also showed improved physiological marker of aging such as the rate of pharyngeal pumping and higher rate of survival against oxidative and thermal stress. Furthermore, APC was found to moderate the expression of human amyloid beta (Aβ1-42) as well as associated Aβ-induced paralysis in the transgenic CL4176 upon increase in temperature. Furthermore, RNA interference (RNAi)-mediated studies revealed the dependence of downstream regulator -, independent of stress-induced resistance gene in the APC treated . In the present study, we tried to demonstrate the anti-aging activity, longevity and protective effects of APC against cellular stress in , which can lead to the use of this biomolecule in drug development for age-related disorders.